Of note in the Gilead release overnight. If you read the study, hydroxychloroquine has been shown in vitro to reduce remdesivir's efficacy via interfering with remdesivir's mechanism of action. And the results showed a higher reduction in mortality in the patient's on remdesivir alone, versus those commenced on remdesivir while also on hydroxychloroquine.
I took a large position in Gilead overnight, as I expected the left wing media to be all over it. But it appears they only use headlines and social media for research.
Cell Therapy News/Articles, page-4202
-
- There are more pages in this discussion • 13,647 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.025(2.17%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.11 | $7.363M | 6.488M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 94863 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 5000 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |